Bronchitis: Clinical Trials

12 trials for Bronchitis, newest first

ClinicalTrials Daily  ·  Areas  ·  Conditions  ·  Drugs  ·  Sponsors  ·  

12 terminated. 12 Phase 1, 6 Phase 2.

By phase and status

PhaseTrialsStatus
Phase 112Terminated 12
Phase 26Terminated 6

Follow Bronchitis: new trials by email Literature Review of Bronchitis trials Research Report on Bronchitis

Trials (filtered) newest first · largest first

All 12 trials

Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.

TrialPhaseStatusSponsorEnrollmentStartUpdated
Upfront Ruxolitinib for Chronic Graft-vs-host Disease
Ruxolitinib - Chronic Graft Versus Host Disease
Phase 1TerminatedChildren's Hospital Medical Center, Cincinnati12025-02-192026-02-25
Itacitinib for the Treatment of Bronchiolitis Obliterans Syndrome After Donor Hematopoietic Cell Transplant
Itacitinib, Itacitinib Adipate - Bronchiolitis Obliterans
Phase 1TerminatedM.D. Anderson Cancer Center82021-10-082025-11-10
Safety and Efficacy of Itacitinib in Participants With Bronchiolitis Obliterans Syndrome Following Lung Transplantation
Itacitinib - Bronchiolitis Obliterans Syndrome
Phase 1 / Phase 2TerminatedIncyte Corporation232020-02-042025-10-20
Glasdegib for Chronic Graft-Versus-Host Disease
Glasdegib - Chronic Graft Versus Host Disease, Fasciitis
Phase 1 / Phase 2TerminatedFred Hutchinson Cancer Center152019-12-032024-10-29
Human IL-15 (rhIL-15) and Obinutuzumab for Relapsed and Refractory Chronic Lymphocyte Leukemia
rhIL-15, Obinutuzumab - Leukemia, Lymphocytic
Phase 1TerminatedNational Cancer Institute (NCI)12019-07-112022-03-22
Ibrutinib Plus Rituximab for cGVHD Following Allo-SCT
Ibrutinib, Rituximab - Chronic Graft-versus-host-disease
Phase 1 / Phase 2TerminatedDartmouth-Hitchcock Medical Center22019-04-112023-11-28
Infasurf®(Calfactant) Aerosol for Infants With Bronchiolitis-AERO-04
Aerosolized Infasurf - Bronchiolitis
Phase 1TerminatedONY132019-01-122020-10-23
Acupuncture Chemotherapy-Induced Peripheral Neuropathy (CIPN) IRG
Acupuncture, Questionnaires, Hand Function and Balance Tests - Breast Cancer
Phase 1 / Phase 2TerminatedM.D. Anderson Cancer Center42014-07-062018-01-12
Phase I Study of Milatuzumab for Graft Versus Host Disease
milatuzumab - GVHD (Acute or Chronic), Acute Myeloid or Lymphoblastic Leukemia (AML or ALL)
Phase 1TerminatedGilead Sciences122013-12-012021-08-19
Tocilizumab for Treatment of Steroid Refractory Acute Graft-versus-Host Disease
Tocilizumab - Acute Graft Versus Host Disease
Phase 1 / Phase 2TerminatedMedical College of Wisconsin142011-08-082020-02-17
A Study to Assess Safety, Tolerability and Pharmacokinetics of of AZD6553 in Healthy Volunteers and Patients With Chronic Obstructive Pulmonary Disease (COPD)
AZD6553, Placebo - Chronic Obstructive Pulmonary Disease
Phase 1TerminatedAstraZeneca1092010-02-012010-09-24
Pharmacokinetic/Pharmacodynamic of Albinterferon Alfa-2b in Chronic Hepatitis B, eAg+, Infection Subjects
albinterferon alfa-2b, Pegasys® - Chronic Hepatitis B
Phase 1 / Phase 2TerminatedNovartis Pharmaceuticals1412009-07-012011-01-06

Narrower conditions

Bronchiolitis Obliterans Syndrome (10)  ·  Breast Neoplasms (1)  ·  Bronchiolitis (1)  ·  Bronchiolitis Obliterans (1)  ·  Fasciitis (1)  ·  Graft vs Host Disease (1)  ·  Hepatitis B (1)  ·  Hepatitis B, Chronic (1)  ·  Leukemia (1)  ·  Leukemia, Lymphocytic, Chronic, B-Cell (1)  ·  Leukemia, Myelogenous, Chronic, BCR-ABL Positive (1)  ·  Leukemia, Myeloid, Acute (1)  ·  Multiple Myeloma (1)  ·  Myelodysplastic Syndromes (1)  ·  Precursor Cell Lymphoblastic Leukemia-Lymphoma (1)

Broader conditions

Bronchial Diseases (12)  ·  Lung Diseases (12)  ·  Lung Diseases, Obstructive (12)  ·  Respiratory Tract Diseases (12)  ·  Bronchiolitis (11)  ·  Bronchiolitis Obliterans (10)  ·  Immune System Diseases (10)  ·  Organizing Pneumonia (10)  ·  Graft vs Host Disease (9)  ·  Chronic Disease (3)  ·  Disease Attributes (3)  ·  Neoplasms (3)  ·  Pathologic Processes (3)  ·  Pathological Conditions, Signs and Symptoms (3)

Interventions

INCB039110 (2)  ·  itacitinib (2)  ·  Acupuncture Therapy (1)  ·  Interleukin-15 (1)  ·  Rituximab (1)  ·  Surveys and Questionnaires (1)  ·  albinterferon alfa-2b (1)  ·  calfactant (1)  ·  glasdegib (1)  ·  ibrutinib (1)  ·  milatuzumab (1)  ·  obinutuzumab (1)  ·  peginterferon alfa-2a (1)  ·  ruxolitinib (1)  ·  tocilizumab (1)

Sponsors

M.D. Anderson Cancer Center (2)  ·  AstraZeneca (1)  ·  Children's Hospital Medical Center, Cincinnati (1)  ·  Dartmouth-Hitchcock Medical Center (1)  ·  Fred Hutchinson Cancer Center (1)  ·  Gilead Sciences (1)  ·  Incyte Corporation (1)  ·  Medical College of Wisconsin (1)  ·  National Cancer Institute (NCI) (1)  ·  Novartis Pharmaceuticals (1)  ·  ONY (1)

Countries

United States (10)  ·  Belgium (1)  ·  Canada (1)  ·  China (1)  ·  Hong Kong (1)  ·  Poland (1)  ·  Taiwan (1)  ·  Thailand (1)  ·  United Kingdom (1)

Top investigators

Amin Alousi, MD (1)  ·  Joanna Marks-Konczalik (1)  ·  John M Hill, MD (1)  ·  Kay Garcia, DRPH (1)  ·  Kevin C Conlon, M.D. (1)  ·  Kevin O'Hayer, MD (1)  ·  Pooja Khandelwal, MD (1)  ·  Stephanie Lee (1)  ·  T G K Mant, FRCP (UK) FFPM (1)  ·  William R Drobyski, MD (1)  ·  William Wegener, MD, PhD (1)

Results publications

PMID 24995515, PMID 32508818, PMID 33883258, PMID 37698881

NIH funding

2009 (1), 2019 (1)